ストックスクリーナーアプリを入手
2.75
1.10%
0.03
アフターアワーズ：
2.77
0.02
+0.73%
前日終値:
$2.72
開ける：
$2.72
24時間の取引高:
802.71K
Relative Volume:
1.80
時価総額：
$289.33M
収益：
$7.05M
当期純損益:
$-30.43M
株価収益率:
-7.2598
EPS:
-0.3788
ネットキャッシュフロー:
$21.84M
1週間 パフォーマンス:
-5.50%
1か月 パフォーマンス:
+29.11%
6か月 パフォーマンス:
+65.66%
1年 パフォーマンス:
-21.43%
1日の値動き範囲:
$2.645
$2.76
1週間の範囲:
$2.60
$3.00
52週間の値動き範囲:
$1.07
$4.21
Proqr Therapeutics N V Stock (PRQR) Company Profile
PRQR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PRQR
Proqr Therapeutics N V
|
2.75 | 286.54M | 7.05M | -30.43M | 21.84M | -0.3788 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Proqr Therapeutics N V Stock (PRQR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-29 | 再開されました | Cantor Fitzgerald | Overweight |
| 2025-04-29 | 開始されました | Evercore ISI | Outperform |
| 2025-03-10 | アップグレード | Citigroup | Neutral → Buy |
| 2025-01-10 | 開始されました | Oppenheimer | Outperform |
| 2024-10-29 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-11-08 | アップグレード | Chardan Capital Markets | Neutral → Buy |
| 2023-03-30 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2022-12-22 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2022-02-14 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-02-11 | ダウングレード | Raymond James | Strong Buy → Mkt Perform |
| 2022-02-11 | ダウングレード | Stifel | Buy → Hold |
| 2022-02-01 | 開始されました | Raymond James | Strong Buy |
| 2021-05-03 | 開始されました | Stifel | Buy |
| 2021-03-25 | 繰り返されました | Citigroup | Buy |
| 2020-11-03 | 再開されました | Cantor Fitzgerald | Overweight |
| 2019-03-12 | 繰り返されました | Chardan Capital Markets | Buy |
| 2018-12-19 | 開始されました | RBC Capital Mkts | Outperform |
| 2018-11-15 | 開始されました | Citigroup | Buy |
| 2018-09-19 | 開始されました | Evercore ISI | Outperform |
| 2017-09-26 | 繰り返されました | JMP Securities | Mkt Outperform |
| 2016-06-20 | 開始されました | Chardan Capital Markets | Neutral |
| 2014-10-15 | 開始されました | Deutsche Bank | Buy |
| 2014-10-13 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Proqr Therapeutics N V (PRQR) 最新ニュース
Will ProQR Therapeutics N.V. stock gain from government policiesPortfolio Gains Report & Daily Growth Stock Investment Tips - newser.com
How sentiment analysis helps forecast ProQR Therapeutics N.V.2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
What catalysts could drive ProQR Therapeutics N.V. stock higherDay Trade & Weekly Top Stock Performers List - newser.com
ProQR Therapeutics N.V. (NASDAQ:PRQR) Short Interest Update - MarketBeat
Custom watchlist performance reports with ProQR Therapeutics N.V.Bear Alert & Verified Trade Idea Suggestions - newser.com
What’s the recovery path for long term holders of ProQR Therapeutics N.V.July 2025 Snapshot & Daily Profit Focused Screening - newser.com
ProQR Therapeutics N.V. (NASDAQ:PRQR) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Is ProQR Therapeutics N.V. stock a good choice for value investorsMarket Sentiment Summary & High Return Trade Opportunity Guides - newser.com
Visualizing ProQR Therapeutics N.V. stock with heatmapsTrade Entry Summary & Long Hold Capital Preservation Tips - newser.com
Is ProQR Therapeutics N.V. stock cheap at current valuationJuly 2025 PostEarnings & Precise Buy Zone Identification - newser.com
Is ProQR Therapeutics N.V. stock attractive for growth ETFsJuly 2025 Fed Impact & Low Drawdown Investment Strategies - newser.com
ProQR Therapeutics NV expected to post a loss of 10 cents a shareEarnings Preview - TradingView
ProQR Therapeutics (PRQR) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Why analysts recommend ProQR Therapeutics N.V. (0PQ) stockMarket Volume Report & Entry Point Confirmation Signals - newser.com
Does ProQR Therapeutics N.V. stock trade at a discount to peersBreakout Watch & Low Risk High Win Rate Picks - newser.com
Key metrics from ProQR Therapeutics N.V.’s quarterly dataWeekly Risk Report & AI Powered Market Entry Strategies - newser.com
Is ProQR Therapeutics N.V. (0PQ) stock at risk of policy regulation2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
Will ProQR Therapeutics N.V. stock outperform international peersQuarterly Portfolio Summary & Technical Confirmation Trade Alerts - newser.com
ProQR Therapeutics (NASDAQ:PRQR) Stock Passes Above 50-Day Moving AverageTime to Sell? - MarketBeat
Is ProQR Therapeutics N.V. stock a safe buy before earnings2025 Technical Patterns & AI Forecast for Swing Trade Picks - fcp.pa.gov.br
Proqr Therapeutics N V (PRQR) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):